ArticleAntimicrobial agents and chemotherapy2013

In vitro and in vivo activities of AIC292, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor.

Steffen Wildum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.